Loading company…
Vivostat A/S develops the Vivostat System, which prepares autologous fibrin sealants and platelet-rich matrices during surgery.
Founded in 2000 in Denmark, Vivostat A/S makes the Vivostat System for on-site preparation of autologous concentrated fibrin sealants and platelet-rich fibrin matrices in surgery. Its products include ArthroZheal® and Obsidian® RFT, and sales go directly to hospitals and surgical centers. Sven Lange is CEO. The company raised USD 9.3 mn on February 5, 2007, from investors including Dansk Erhvervsinvestering and DKA Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in